Mako just posted a comment that AF's investigative due diligence on CTIX will be the greatest of 2017. Too funny...a small biotech startup that is trying to get its three drugs through clinical trials with a $125M market cap and AF's distortion of the facts will be so appreciated by investors everywhere. What an absolute joke. They act as if the stock is at $100 SP based upon bogus results. Sounds to me like someone is simply butt hurt over the dismissal of the Rosen lawsuit. Hang toug longs....this much interest over a small start up biotech does not just happen....